These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2565515

  • 1. Oral contraceptive use and breast cancer risk in young women. UK National Case-Control Study Group.
    Lancet; 1989 May 06; 1(8645):973-82. PubMed ID: 2565515
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR.
    Clin Obstet Gynaecol; 1984 Dec 06; 11(3):759-86. PubMed ID: 6509858
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports.
    Hawley W, Nuovo J, DeNeef CP, Carter P.
    J Am Board Fam Pract; 1993 Dec 06; 6(2):123-35. PubMed ID: 8452064
    [Abstract] [Full Text] [Related]

  • 10. Potential for bias in case-control studies of oral contraceptives and breast cancer.
    Skegg DC.
    Am J Epidemiol; 1988 Feb 06; 127(2):205-12. PubMed ID: 3276164
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep 06; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. General practitioner notes as a source of information for case-control studies in young women. UK National Case-Control Study Group.
    Chilvers CE, Pike MC, Taylor CN, Hermon C, Crossley B, Smith SJ.
    J Epidemiol Community Health; 1994 Feb 06; 48(1):92-7. PubMed ID: 8138777
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Age-specific differences in the relationship between oral contraceptive use and breast cancer.
    Wingo PA, Lee NC, Ory HW, Beral V, Peterson HB, Rhodes P.
    Cancer; 1993 Feb 15; 71(4 Suppl):1506-17. PubMed ID: 8431887
    [Abstract] [Full Text] [Related]

  • 18. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK, Chick P.
    Med J Aust; 1992 Jan 20; 156(2):124-32. PubMed ID: 1736053
    [Abstract] [Full Text] [Related]

  • 19. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr 26; 349(9060):1202-9. PubMed ID: 9130941
    [Abstract] [Full Text] [Related]

  • 20. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group.
    Rookus MA, van Leeuwen FE.
    Lancet; 1994 Sep 24; 344(8926):844-51. PubMed ID: 7916400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.